| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3437797 | American Journal of Obstetrics and Gynecology | 2009 | 8 Pages |
Abstract
In pathologic FIGO stage 1 and 2A endometrioid endometrial cancer curettages, combined biomarkers survivin, p21, and p53 expression patterns are prognostically stronger than classical feature combinations.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Anita MD, Ivar MSc, Einar MD, Emiel A.M. PhD, Kjell H. MD, Jan MD, Kjell MD, Bent MD, Jan P.A. MD, PhD, FRCPath, FIAC(Hon),